Cancer Immunity Ceases Publication, CRI and AACR to Collaborate on New Journal Cancer Immunology Research

In 2001, the Cancer Research Institute (CRI), along with the Academy of Cancer Immunology, launched an important new journal, Cancer Immunity. Led by inaugural Editor-in-Chief Dr. Lloyd J. Old, a world-renowned cancer immunologist, the journal was, at the time, the only journal devoted to all aspects of cancer immunology. Since the journal’s launch, it has disseminated many types of influential content important to cancer immunologists, including original research articles, reviews, hypotheses, case reports, and conference proceedings. We are writing to let you know that Cancer Immunity has published its final issue in July 2013.

Although Cancer Immunity is ceasing publication, we are pleased to announce a new collaboration between CRI and the American Association for Cancer Research (AACR) that will preserve the legacy of Dr. Old’s vision and the journal he founded.

On July 11, 2013, AACR launched Cancer Immunology Research, www.cancerimmunolres.aacrjournals.org, a new journal that will publish research articles reporting major advances in all areas of cancer immunology. Dr. James Allison, editor-in-chief of Cancer Immunity, will serve Cancer Immunology Research as a deputy editor. A portion of the journal will be devoted to CRI-related events and activities, and our partnership will be highlighted on the journal’s cover.

In addition, Cancer Immunity content will be relocated to the Cancer Immunology Research online journal site by the end of 2013. This will allow readers additional access to preeminent cancer immunology content in one location. In the meantime, you can still visit our archives and valuable scientific resources, such as the Peptide Database, SEREX Review, LICR Tetramer Collection, and much more on www.cancerimmunity.org.

We encourage you to learn more of Cancer Immunology Research’s editorial scope and to submit future papers to this new journal that will further accelerate progress in cancer immunology and immunotherapy research and clinical application.

To learn more about the new collaboration on the journal, you may read the joint news release and letter by Drs. Glen Dranoff and Jim Allison published in Cancer Immunology Research.